Navigation Links
Two-year data for Angiotech's Vascular Wrap Paclitaxel-Eluting Mesh,to be Presented at European Vascular Symposium

al disease, other factors referenced in our annual information form and other filings with the applicable Canadian securities regulatory authorities or the Securities and Exchange Commission; and any other factors that may affect performance.

In addition, our business is subject to certain operating risks that may cause the actual results expressed or implied by the forward-looking statements in this report to differ materially from our actual results. These operating risks include: our ability to successfully complete preclinical and clinical development of our products; the ability to obtain and enforce timely patent and other intellectual property protection for our technology and products; decisions, and the timing of decisions, made by health regulatory agencies regarding approval of our technology and products; the ability to complete and maintain corporate alliances relating to the development and commercialization of our technology and products; market acceptance of our technology and products; the competitive environment and impact of technological change; the continued availability of capital to finance our activities; our ability to integrate into our business the operations of AMI; and, our ability to achieve the operational and other synergies and the other commercial or financial benefits expected as a result of the acquisition of AMI.

Given these uncertainties, assumptions and risk factors, readers are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained in this report to reflect future results, events or developments.

    Vascular Wrap(TM) is a trademark of Angiotech Pharmaceuticals, Inc.

    (C) 2007 Angiotech Pharmaceuticals, Inc. All rights reserved.

CONTACT: Janet Craig, VP, Investor Relations and Corporate Communications, Angiotech Ph
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
2. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
3. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
4. Abbott to Present New Data Across its Vascular Portfolio at the American College of Cardiologys 56th Annual Scientific Session
5. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Clinical Data From Nymox BPH Drug To Be Presented at American Urological Association Meeting
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
Post Your Comments:
(Date:5/24/2013)...  Sinovac Biotech Ltd. (NASDAQ: SVA ... China , announced that Sinovac ... obtained the Certificate of Good Manufacturing Practices for ... and Food Administration (CFDA) for its proprietary vaccines, ... Changping filing and packaging facility. The GMP certificate ...
(Date:5/23/2013)... y PARÍS, 24 de mayo de 2013 /PRNewswire/ ... destacado desarrollador y fabricante de herramientas de precisión ... y tratamiento de la enfermedad vascular periférica y ... ADVISE ( Ad enosine V asodilator ... II durante la sesión de ensayo clínico hot ...
(Date:5/23/2013)... , May 23, 2013 Hearing health affects a ... younger, and remain socially and professionally engaged, he should address ... overriding message that the Better Hearing Institute (BHI) ... National Men,s Health Week , which leads up to ... runs from June 10 through June 16. ...
Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 2Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 3Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 4Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 5Volcano anuncia los resultados preliminares del estudio ADVISE II y su inclusión en el ensayo SYNTAX2 6Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 2Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 3Men Who Want to Stay Active, Feel Younger, and Remain Socially and Professionally Engaged Should Address Hearing Loss, BHI Advises 4
... , ST. LOUIS, Jan. 7 KV ... the inspector of elections retained by the Company, has certified ... received by the Company on December 22, 2009 (the "Written ... stockholders (the "Director Changes") are sufficient to approve the matters ...
... , TUCSON, Ariz., Jan. 7 The Providence Service ... and Chief Executive Officer, is scheduled to present an overview of ... Cap Conference on Monday, January 11, 2010 at The Grand Hyatt ... 1:50 p.m. ET. , On Thursday, January 14, 2010, ...
Cached Medicine Technology:KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 2KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 3KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 4KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 5KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 6KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director 7Providence Service Corporation to Present at the Sidoti & Company, LLC Micro Cap Conference on Monday, January 11th and at the CJS Securities 'New Ideas for the New Year' Conference on Thursday, January 14th 2
(Date:5/25/2013)... Forney, United States (PRWEB) May 25, 2013 ... oldest and largest underground shelter company in the ... and composite underground structures for over 35 years. ... of PROTECTION, U.S. Handbook of NBC Weapon Fundamentals ... is the United States’ bible on shelter engineering. ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Absolute Surgical Specialists, ... many of the NALA’s businesses throughout the country participating in ... to participate in the nationwide event as he understands what ... Colonel in the Army. He said, “I wanted to give ... I serve, but I live here too.” , Shop Local ...
(Date:5/25/2013)... 25, 2013 The latest report ... irritable bowel syndrome (IBS) to bloating, constipation, diarrhea ... most long-lasting, embarrassing, frustrating and difficult health issues ... digestive health have provided a cure for ... factors contributing to digestive health issues, a healthy ...
(Date:5/25/2013)... 2013 According to a new ... 2013–2018", published by MarketsandMarkets is expected to reach ... 5.54% which analyzes and studies the major market ... Asia, and Rest of the World. , Browse:, ... , 87 Figures , ...
(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2Health News:Natural Foods For Digestive Health Report and Video Published by BetterDigestion.org 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 2Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 3Health News:Homeland Security Market to Reach $544.02 Billion by 2018 at a CARC of 5.54% - New Report by MarketsandMarkets 4Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... Profitability, CARLSBAD, Calif., Feb. 12 Genoptix, Inc.,(Nasdaq: ... reported,revenues of $18.6 million for the fourth quarter ended ... $7.8 million for the comparable period,in 2006. For the ... of $59.3 million, an increase of 147% over revenues ...
... Feb. 12 AtriCure, Inc.,(Nasdaq: ATRC ), a ... products, announced today that David J. Drachman, President and,Chief ... Capital,Partners 20th Annual OC Growth Stock Conference at the ... February 20th at 2:00 p.m.,PT., A live web ...
... of anxiety may cause women with ductal carcinoma in ... cancer, to overestimate their risk of recurrence or dying ... at Dana-Farber Cancer Institute in Boston. , "Although DCIS ... DCIS develop inaccurate risk perceptions," said Ann Partridge, MD, ...
... answers the research offers , , TUESDAY, Feb. 12 ... one of the most pressing questions in critical care ... open the partially collapsed lungs of people being treated ... , Unfortunately, that question has not been definitively answered. ...
... cancer specialists at Jeffersons Kimmel Cancer Center in Philadelphia ... for liver cancer. The therapy entails injecting tiny beads ... main artery while also blocking the blood supply feeding ... been approved by the federal Food and Drug Administration ...
... 50, 75 and 100 mcg/hr) Not Affected, ... Pharmaceuticals, Inc. said today that all lots of ... by PriCara in the United States and all ... the United States are being voluntarily,recalled as a ...
Cached Medicine News:Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 2Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 3Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 4Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 5Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 6Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 7Health News:Genoptix Reports Strong Financial Results for the Fourth Quarter and Full Year 2007 8Health News:AtriCure to Present at Roth Capital Partners 20th Annual OC Conference 2Health News:Anxiety linked to newly diagnosed DCIS patients' overestimation of breast cancer risks 2Health News: Respiratory Distress Treatment Studies Conflict 2Health News: Respiratory Distress Treatment Studies Conflict 3Health News:New Jefferson trial to test radiation-emitting beads against advanced liver cancer 2Health News:PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: